Career Search
Explore opportunities with Novartis below.
Notice to applicants for US job openings. Learn More
Showing 2098 results
- Sort by Sort ascending
- Job Title Sort ascending
- Business
- Location
- Site
- Date Posted
| Job Title Sort ascending | Business | Location | Site | Date Posted |
|---|---|---|---|---|
| Principal Scientist II Regular, Full time | Research | USA | San Diego | Jan 29, 2026 |
| Executive Director, Field Skills & Capability-Development-Remote Regular, Full time | Finance | USA | Remote Position (USA) | Jan 29, 2026 |
| Data Platform Sr. Specialist DDIT US&I D&A Operations Regular, Full time | Information Technology | Mexico | INSURGENTES | Jan 29, 2026 |
| Maintenance Technician Regular, Full time | Production / Manufacturing | USA | Indianapolis | Jan 29, 2026 |
| Site IT Specialist Regular, Full time | Information Technology | USA | Durham | Jan 29, 2026 |
| Buyer (Mandarin speaker) 正式, Full time | Purchasing & Sourcing | Malaysia | Selangor | Jan 28, 2026 |
| Assistant chef de produit dermatologie (Maladie de Verneuil) en stage Early Career (durée déterminée), Full time | Marketing | France | Paris Headquarter (PHARMA) | Jan 28, 2026 |
| Assistant chef de produit (maladie de Verneuil) en stage Early Career (durée déterminée), Full time | Marketing | France | Paris Headquarter (PHARMA) | Jan 28, 2026 |
| Associate Director, Therapeutic Area (Cardiovascular & Metabolism (CVM)), Enterprise Competitive Intelligence Regular, Full time | General Management | India | Hyderabad (Office) | Jan 28, 2026 |
| Associate Director, Strategic CI, Enterprise Competitive Intelligence Regular, Full time | General Management | India | Hyderabad (Office) | Jan 28, 2026 |
Pagination
- ‹ Previous page
- 1
- …
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- …
- 210
- › Next page
Adverse Event Reporting
We encourage using the following electronic reporting tool for reporting into the safety database directly: https://www.report.novartis.com/
If electronic reporting tool is not working – please use the following Generic mailbox: [email protected]
CISCO: +20 2 22861000: Press 3 for Adverse Event Reporting